Clinical Trial Update: Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy, safety, and quality of life after VTP treatment with TOOKAD Soluble for intermediate-risk prostate cancer. Results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TOOKAD Soluble (padeliporfin)

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Localized Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-08-02